An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation

Registry ID

EUCTR2013-001650-94

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Allergan Limited

Start date

2013-07-11

Completion date

2017-08-15

Last update

2026-08-16

Conditions

• Premature Ejaculation

Summary

To explore the safety and efficacy profile of a range of doses of BOTOX for the treatment of premature ejaculation in male patients

Locations

• , , UK

Related clinical trials

• Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)
• Pelvic Floor Therapies for Lifelong Premature Ejaculation
• The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation
• Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
• Ejaculatory and Orgasmic Dysfunction Registry
• Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients

View on source registry